Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2026 12:30 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea-Aktionäre genehmigen an der Generalversammlung 2026 alle Anträge des Verwaltungsrats

Allschwil, 15. April 2026 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
April 15, 2026 12:30 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting

Allschwil, Switzerland, April 15, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
April 14, 2026 08:30 ET | Source: Draganfly Inc

Draganfly CEO Cameron Chell Addresses Canadian Senate on Strengthening National Defence Capability

Ottawa, ON, April 14, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer,...
April 10, 2026 08:30 ET | Source: Draganfly Inc

Draganfly CEO Cameron Chell to Appear on Fox Business’ Making Money with Charles Payne to Discuss Iran Conflict and the Strategic Role of Drone Warfare

New York, NY, April 10, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading developer of drone solutions...
April 09, 2026 10:30 ET | Source: Multitude AG

Multitude AG: Mr Jorma Jokela, Receipt of a share-based incentive; Transaction linked to the exercise of share option programmes

Multitude AG: Mr Jorma Jokela, Receipt of a share-based incentive; Transaction linked to the exercise of share option programmes Notification and public disclosure of transactions by persons...